Grantham, Mayo, Van Otterloo & Co (GMO)’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
12,095
-16,149
-57% -$382K ﹤0.01% 603
2026
Q1
$617K Sell
28,244
-21,204
-43% -$492K ﹤0.01% 546
2025
Q4
$1.15M Buy
49,448
+37,042
+299% +$893K ﹤0.01% 496
2025
Q3
$351K Buy
+12,406
New +$330K ﹤0.01% 551
2025
Q2
Sell
-22,862
Closed -$533K 641
2025
Q1
$533K Sell
22,862
-1,214,975
-98% -$31.1M ﹤0.01% 544
2024
Q4
$35.6M Buy
1,237,837
+47,832
+4% +$1.43M 0.12% 114
2024
Q3
$35.3M Buy
1,190,005
+128,211
+12% +$3.98M 0.11% 131
2024
Q2
$35.8M Buy
1,061,794
+73,612
+7% +$2.54M 0.12% 115
2024
Q1
$35.7M Buy
988,182
+433,392
+78% +$15M 0.13% 114
2023
Q4
$18.1M Sell
554,790
-39,001
-7% -$1.2M 0.08% 183
2023
Q3
$19.3M Buy
593,791
+94,200
+19% +$3.02M 0.09% 184
2023
Q2
$14.6M Hold
499,591
0.07% 214
2023
Q1
$14M Buy
499,591
+167,335
+50% +$4.71M 0.07% 214
2022
Q4
$9.06M Buy
332,256
+11,267
+4% +$301K 0.05% 247
2022
Q3
$7.65M Buy
+320,989
New +$8.81M 0.04% 268
2021
Q1
Sell
-30,248
Closed -$1.03M 882
2020
Q4
$1.03M Sell
30,248
-13,400
-31% -$413K 0.01% 562
2020
Q3
$1.12M Hold
43,648
0.01% 498
2020
Q2
$1.13M Buy
43,648
+100
+0.2% +$2.51K 0.01% 511
2020
Q1
$965K Sell
43,548
-31,500
-42% -$875K 0.01% 503
2019
Q4
$2.17M Buy
75,048
+4,400
+6% +$124K 0.01% 385
2019
Q3
$1.95M Buy
70,648
+15,900
+29% +$420K 0.01% 438
2019
Q2
$1.35M Buy
+54,748
New +$1.24M 0.01% 497
2019
Q1
Sell
-84,200
Closed -$1.7M 718
2018
Q4
$1.7M Sell
84,200
-20,800
-20% -$436K 0.01% 303
2018
Q3
$2.25M Buy
+105,000
New +$2.43M 0.02% 294
2017
Q3
Sell
-249,429
Closed -$4.73M 589
2017
Q2
$4.73M Sell
249,429
-31,800
-11% -$620K 0.03% 248
2017
Q1
$6M Buy
281,229
+47,266
+20% +$992K 0.03% 221
2016
Q4
$4.61M Buy
233,963
+52,787
+29% +$961K 0.02% 246
2016
Q3
$3.18M Sell
181,176
-221,896
-55% -$3.83M 0.02% 291
2016
Q2
$6.23M Buy
403,072
+136,791
+51% +$2.17M 0.03% 276
2016
Q1
$4.18M Buy
266,281
+25,000
+10% +$364K 0.02% 309
2015
Q4
$3.86M Sell
241,281
-18,100
-7% -$292K 0.01% 282
2015
Q3
$4.02M Sell
259,381
-10,471
-4% -$166K 0.01% 263
2015
Q2
$4.43M Sell
269,852
-82,700
-23% -$1.45M 0.01% 261
2015
Q1
$6.45M Sell
352,552
-13,200
-4% -$233K 0.02% 237
2014
Q4
$6.61M Sell
365,752
-64,288
-15% -$1.07M 0.02% 229
2014
Q3
$5.76M Sell
430,040
-26,160
-6% -$380K 0.02% 256
2014
Q2
$6.63M Buy
456,200
+182,200
+66% +$2.66M 0.02% 228
2014
Q1
$4.32M Buy
+274,000
New +$4.37M 0.01% 318

Other funds holding GNTX

Grantham, Mayo, Van Otterloo & Co (GMO)'s GNTX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Gentex (GNTX) stake by 57% in Q2 2026, selling an estimated $382K and leaving 12,095 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #603.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GNTX in Q1 2014 and has held it in 38 quarters since. The position peaked at $35.8M in Q2 2024. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 12,095 shares of Gentex worth $306K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 16,149 Gentex shares in Q2 2026, an estimated $382K.
  • Gentex made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #603 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Gentex in Q1 2014 and has held it in 38 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Gentex position peaked at $35.8M in Q2 2024.
  • 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.